2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Pocket Pal
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee
Industry Insight

Industry Insights: Clinical Perspectives on Refractory Shock Management: Advanced Decision-Making in Vasopressor Strategy, Perfusion, and Escalation

Monday, March 23, 2026
12:15 PM - 1:00 PM Central Time
Location: W178

    Symposium Faculty(s)

  • Richard Wunderink, MD

    Disclosure information not submitted.

  • David Boldt, MD

    Disclosure(s): Innoviva Specialty Therapeutics: Consultant (Ongoing)

  • Samir Awad, MD

    Disclosure(s): Innoviva Specialty Therapeutics: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanara MedTech: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TelaBio: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Sponsored by Innoviva
Register here: bit.ly/4RPVAFT
Complimentary lunch will be provided. Breakfast is limited and available on a first-come, first-served basis.
Despite adherence to evidence‑based protocols, septic shock frequently evolves in ways that defy expectations. This expert-led symposium is designed for experienced critical care clinicians seeking deeper insight into how shock pathophysiology, perfusion, and vasopressor responsiveness change as patients progress beyond routine management. Through case‑based discussion and moderated expert dialogue, faculty will explore how seasoned clinicians recognize key inflection points, assess and reassess physiology and pathophysiology when perfusion targets are unmet, and weigh the risks and benefits of vasopressor options and strategies. Emphasis will be placed on real‑world decision‑making where comorbidities, organ vulnerability, trajectory, and/or phenotype shape patient‑specific management decisions more than algorithms alone. This session moves beyond introductory concepts to examine how experts think when septic shock becomes refractory, incorporating perspectives from medical, surgical, and anesthesiology‑led critical care environments.
 Visit Innoviva at booth #993 to learn more.

Learning Objectives:

  • Differentiate distributive shock phenotypes and recognize physiologic signals that suggest progression toward refractory shock
  • Evaluate vasopressor escalation options and strategies based on patients’ clinical characteristics, response/trajectory, and evolving risk, rather than dose thresholds alone
  • Consider novel and advanced perfusion assessment principles beyond mean arterial pressure to support consistent, mechanism-informed decision-making in complex shock scenarios